You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

CLINICAL TRIALS PROFILE FOR MALATHION


✉ Email this page to a colleague

« Back to Dashboard


505(b)(2) Clinical Trials for MALATHION

This table shows clinical trials for potential 505(b)(2) applications. See the next table for all clinical trials
Trial Type Trial ID Title Status Sponsor Phase Start Date Summary
OTC NCT00244439 ↗ Safety and Efficacy of a Novel Malathion Formulation in the Treatment of Head Lice Completed Taro Pharmaceuticals USA Phase 3 2005-12-01 Current treatments for head lice include over-the-counter products such as permethrin and prescription products such as OVIDE (malathion 0.5%) lotion. In a previous phase II study, a novel, easy-to-use malathion 0.5% formulation was found to be a safe treatment for head lice. The current study will compare the efficacy and safety of this novel formulation of malathion with OVIDE and with an over-the-counter permethrin product.
New Formulation NCT00927472 ↗ Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice Completed Taro Pharmaceuticals USA Phase 3 2009-08-01 In this study, Malathion Gel 0.5% will be compared to Nix (permethrin 1%) as a treatment for head lice in patients 2 years of age and older. Malathion Gel 0.5% is a new formulation of an established head lice treatment. The new formulation has been evaluated in 2 previous studies of patients 2 years of age and older.
New Formulation NCT00963508 ↗ Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice Completed Taro Pharmaceuticals USA Phase 3 2009-08-01 In this study, Malathion Gel 0.5% will be compared to Nix (permethrin 1%) as a treatment for head lice in patients 2 years of age and older. Malathion Gel 0.5% is a new formulation of an established head lice treatment. The new formulation has been evaluated in 2 previous studies of patients 2 years of age and older.
>Trial Type >Trial ID >Title >Status >Phase >Start Date >Summary

All Clinical Trials for MALATHION

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00244439 ↗ Safety and Efficacy of a Novel Malathion Formulation in the Treatment of Head Lice Completed Taro Pharmaceuticals USA Phase 3 2005-12-01 Current treatments for head lice include over-the-counter products such as permethrin and prescription products such as OVIDE (malathion 0.5%) lotion. In a previous phase II study, a novel, easy-to-use malathion 0.5% formulation was found to be a safe treatment for head lice. The current study will compare the efficacy and safety of this novel formulation of malathion with OVIDE and with an over-the-counter permethrin product.
NCT00291057 ↗ Safety and Tolerability of a Novel Malathion Formulation in Infants and Toddlers With Head Lice Terminated Taro Pharmaceuticals USA Phase 2 2006-02-01 In a previous phase II study, the safety and efficacy of a novel formulation of malathion 0.5% was evaluated in patients 2 years of age and older. Based on the results of that study, this formulation is currently in a phase III study for that population. The current study will use blood markers and clinical evaluations to determine the safety and tolerability of this formulation when used in children 6-24 months of age.
NCT00752973 ↗ Safety and Tolerability of a Novel Malathion Formulation in Children Age 6-24 Months With Head Lice Completed Taro Pharmaceuticals USA Phase 2/Phase 3 2008-09-01 In a previous phase II study, the safety and efficacy of a novel formulation of malathion 0.5% was evaluated in patients 2 years of age and older. Based on the results of that study, this formulation is currently in a phase III study for that population. The current study will use blood markers and clinical evaluations to determine the safety and tolerability of this formulation when used in children 6-24 months of age.
NCT00819520 ↗ Ivermectin in the Treatment of Head Lice Completed Johnson & Johnson Consumer and Personal Products Worldwide Phase 3 2004-02-01 The purpose of this study is to compare 2 single doses of ivermectin as tablets with 2 single applications of malathion 0.5% lotion (Days 1 and 8) in clearing head lice, in patients who have recently used standard head lice treatments without success.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for MALATHION

Condition Name

Condition Name for MALATHION
Intervention Trials
Pediculosis 4
Lice Infestations 3
Head Lice 1
Scabies 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for MALATHION
Intervention Trials
Lice Infestations 8
Parasitic Diseases 3
Scabies 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for MALATHION

Trials by Country

Trials by Country for MALATHION
Location Trials
United States 15
Israel 1
France 1
Ireland 1
Solomon Islands 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for MALATHION
Location Trials
Arkansas 3
Florida 3
Ohio 2
New York 2
Arizona 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for MALATHION

Clinical Trial Phase

Clinical Trial Phase for MALATHION
Clinical Trial Phase Trials
Phase 3 5
Phase 2/Phase 3 1
Phase 2 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for MALATHION
Clinical Trial Phase Trials
Completed 7
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for MALATHION

Sponsor Name

Sponsor Name for MALATHION
Sponsor Trials
Taro Pharmaceuticals USA 6
Johnson & Johnson Consumer and Personal Products Worldwide 1
London School of Hygiene and Tropical Medicine 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for MALATHION
Sponsor Trials
Industry 7
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.